Riskpilot← Back to searchSign inGet full accessMJW Mediqa AB
ABActiveOrg 5562591635Västra Sörbys Bygata 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19852 employees
Revenue 2025
SEK 4,1M
+6% vs 2024
EBITDA margin
37.7%
+1% vs 2024
Equity ratio
33.9%
Financial strength
Net profit 2025
SEK 895K
+2% vs 2024
| Revenue | SEK 4,1M | +6% |
| EBITDA | SEK 1,6M | +1% |
| Net profit | SEK 895K | +2% |
| Total assets | SEK 3M | +8% |
| Equity | SEK 1M | -1% |
| Employees | 2 | — |
Legal name
MJW Mediqa AB
Org number
5562591635
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2 maj 1985
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet ska vara marknadsföring, försäljning och utveckling av medicintekniska produkter och därmed förenlig verksamhet.
Address
Västra Sörbys Bygata 6
Phone
+46709803939
Email
jw@mediqa.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 3 014 | 2 941 | 3 165 | 3 201 | 3 509 | 3 962 | 3 918 | 4 143 |
| Staff expenses | — | — | — | — | — | — | −1 328 | — | — | −1 689 |
| EBITDA | −472 | 96 | 819 | 846 | 767 | 1 271 | 1 639 | 1 861 | 1 542 | 1 560 |
| Depreciation & amort. | −95 | −24 | −9 | −0 | −6 | −33 | −39 | −39 | −40 | −53 |
| EBIT | −567 | 72 | 810 | 846 | 761 | 1 238 | 1 599 | 1 822 | 1 502 | 1 507 |
| Net financials | −17 | −17 | −15 | −9 | −9 | −10 | −8 | −7 | −1 | 8 |
| Profit before tax | −385 | 56 | 679 | 625 | 752 | 1 228 | 1 192 | 2 043 | 1 116 | 1 132 |
| Tax | −0 | −0 | −77 | −141 | −167 | −264 | −247 | −425 | −239 | −237 |
| Net profit | −385 | 56 | 602 | 484 | 585 | 964 | 945 | 1 618 | 877 | 895 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 353 | 1 390 | 1 739 | 1 821 | 1 915 | 2 424 | 2 786 | 3 197 | 2 775 | 2 994 |
| Equity | 446 | 502 | 724 | 609 | 713 | 1 087 | 1 073 | 1 750 | 1 027 | 1 016 |
| Long-term debt | 200 | 200 | 182 | 162 | 122 | 102 | 82 | 0 | 0 | — |
| Short-term debt | 707 | 688 | 717 | 723 | 752 | 907 | 905 | 947 | 862 | 708 |
| Total debt | 907 | 888 | 899 | 885 | 874 | 1 009 | 986 | 947 | 862 | 708 |
EBITDA margin
37.7%
This company
15.8%
Market median
+139% vs market
20162025
Equity ratio
33.9%
This company
38.2%
Market median
+11% vs market
20162025
Return on equity
88.1%
This company
18.4%
Market median
+379% vs market
20162025
Net profit margin
21.6%
This company
8.1%
Market median
+167% vs market
20162025
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20162025
Debt / equity
1.95×
This company
0.62×
Market median
-215% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PG Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2026 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MJW Mediqa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Göran Eriksson | Audit | 0 companies |
| Hans Ola Magnusson | Deputy Board Member | 0 companies |
| Jens Magnus Weiland | Chairman | 0 companies |
| Barbro Ulrika Davidsson | Board of Directors | 0 companies |
| Barbro Ulrika Davidsson | Board of Directors | 0 companies |
| Hans Roland Magnusson | Deputy Board Member | 0 companies |